Your browser doesn't support javascript.
loading
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith, Matthew R; Scher, Howard I; Sandhu, Shahneen; Efstathiou, Eleni; Lara, Primo N; Yu, Evan Y; George, Daniel J; Chi, Kim N; Saad, Fred; Ståhl, Olof; Olmos, David; Danila, Daniel C; Mason, Gary E; Espina, Byron M; Zhao, Xin; Urtishak, Karen A; Francis, Peter; Lopez-Gitlitz, Angela; Fizazi, Karim.
Afiliação
  • Smith MR; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: smith.matthew@mgh.harvard.edu.
  • Scher HI; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sandhu S; Peter MacCallum Cancer Center and University of Melbourne, Melbourne, VIC, Australia.
  • Efstathiou E; Houston Methodist Cancer Center, Houston, TX, USA.
  • Lara PN; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
  • Yu EY; Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • George DJ; Duke Cancer Institute, Durham, NC, USA.
  • Chi KN; University of British Columbia, BC Cancer Vancouver Center, Vancouver, BC, Canada.
  • Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Ståhl O; Department of Oncology, Skane University Hospital, Lund, Sweden.
  • Olmos D; Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Danila DC; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mason GE; Janssen Research & Development, Spring House, PA, USA.
  • Espina BM; Janssen Research & Development, Los Angeles, CA, USA.
  • Zhao X; Janssen Research & Development, San Francisco, CA, USA.
  • Urtishak KA; Janssen Research & Development, Spring House, PA, USA.
  • Francis P; Janssen Research & Development, New Brunswick, NJ, USA.
  • Lopez-Gitlitz A; Janssen Research & Development, Los Angeles, CA, USA.
  • Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
Lancet Oncol ; 23(3): 362-373, 2022 03.
Article em En | MEDLINE | ID: mdl-35131040
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article